| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2006 | CN1714809A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714799A Medicinal composition and its use in treating osteoarthritis |
| 01/04/2006 | CN1714798A Medicinal coposition for treating cardiocerebral vascular diseases |
| 01/04/2006 | CN1714797A Medicinal use of paeoniflorin |
| 01/04/2006 | CN1714796A Medicine for treating cardiocerebral vascular diseases |
| 01/04/2006 | CN1714795A Eye drop and its preparing method and use |
| 01/04/2006 | CN1714794A Irbesartan hydrochlorothiazine dispersible tablet an dits preparing method |
| 01/04/2006 | CN1714793A Famciclovir slow-releasing capsule for anti-virus treatment and its producing method |
| 01/04/2006 | CN1714792A Composition of epigallocatechin, gallate and folic acid and its use |
| 01/04/2006 | CN1714791A Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 01/04/2006 | CN1714790A Fibrauretine transfusion preparation and its preparing method |
| 01/04/2006 | CN1714789A Candesartan hydrochlorothiazine dispersible tablet and its preparing method |
| 01/04/2006 | CN1714788A Tinidazole powder injection and its preparing method |
| 01/04/2006 | CN1714787A Tromethamine gel form medicinal composition |
| 01/04/2006 | CN1714786A Medicinal composition of silibin |
| 01/04/2006 | CN1714785A Concentrated emulsifier containing taxol compound and its using method |
| 01/04/2006 | CN1234721C Androgenic 7-substituted 11-halogen steroids |
| 01/04/2006 | CN1234718C New macrolides with antibacterial activity |
| 01/04/2006 | CN1234717C N, O-carboxymethyl chitoligose, its preparation and use |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/04/2006 | CN1234707C Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234700C Taxone bromated analog with anticancer activity and preparation method thereof |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234696C Taxad alkyl derivative and its prepn. process |
| 01/04/2006 | CN1234695C N-alkoxyalkyl-substituted benzimidazoles and use thereof as active agent against parasitic protozoans |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234679C Shortened synthesis of 3, 3-diaryl propylamine derivatives |
| 01/04/2006 | CN1234414C Drugs for complications of diabetes and neuropathy and utilization thereof |
| 01/04/2006 | CN1234409C Combination of medication for treating depression and preparation method |
| 01/04/2006 | CN1234402C Method for treating bone fracture |
| 01/04/2006 | CN1234385C Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia |
| 01/04/2006 | CN1234382C Medicine ointment for treating women's leukoplakia vulvae and valval pruritus |
| 01/04/2006 | CN1234380C Fracture setting medicine powder and its preparing process |
| 01/04/2006 | CN1234370C Chinese medicine injection for treating cardio-cerebral vascular diseases and shock first-aid |
| 01/04/2006 | CN1234369C Bacillus prodigiosus polysaccharide for nose drops |
| 01/04/2006 | CN1234368C New medicinal use of liquorice polysaccharide and its medicinal preparation |
| 01/04/2006 | CN1234367C Arylazo-substituted imidazole for treatment of stress urinary incontinence |
| 01/04/2006 | CN1234366C Use of active vitamin D analogue in preparing medicine for treating hyperproliferative diseases |
| 01/04/2006 | CN1234365C Compound preparation for treating psoriasis vulgaris and its preparation process |
| 01/04/2006 | CN1234364C Gel composition for killing parasites |
| 01/04/2006 | CN1234363C Freezing-dried composition contg. dexrazoxane and its prepn. method |
| 01/04/2006 | CN1234362C Opioid agonist/antagonist combinations |
| 01/04/2006 | CN1234361C Method for preparing medicine of levo-stephandinine |
| 01/04/2006 | CN1234360C Complementary gain pain-killing medicine |
| 01/04/2006 | CN1234359C Use of oxidized matrine in preparation of chemicals for treating viral myocarditis |
| 01/04/2006 | CN1234358C Benzothiazole derivatives |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234356C Leimaquban solid dispersion, preparation method and oral composition |
| 01/04/2006 | CN1234355C Medicinal composition having anti-inflammation and anti-infection function |
| 01/04/2006 | CN1234354C Aquatic product feed crystal amino acid slow-releasing preparation and its producing method |
| 01/04/2006 | CN1234353C Application of gallic acid in prepn. of medicine for antitumor |
| 01/04/2006 | CN1234352C Treatment of PCP addiction and PCP addiction-related behavior |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/04/2006 | CN1234350C Estrogen plaster used on pessary or intrauterine device |
| 01/04/2006 | CN1234347C Anti-virus composition |
| 01/04/2006 | CN1234346C Optimised formulation of tobramycin for aeroselization |
| 01/04/2006 | CN1234344C Inhalation composition |
| 01/03/2006 | US6982353 C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals |
| 01/03/2006 | US6982351 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor |
| 01/03/2006 | US6982350 reduction of 4,5-dimethoxy-1-cyano-benzocyclobutane, resolution with optically active diacid (N-acetyl-L-glutamic acid), amidification and reduction; improved yield and optical purity; chemical intermediates; antiischemic agents |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 01/03/2006 | US6982337 catalytic condensation of N-(2-hydroxyethyl)-2-pyrrolidone (HEP) in the presence of added water; by-product inhibition of N-ethyl-2-pyrrolidone (NEP) |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982334 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982329 provides synthetic methodology that may be employed to prepare steroid compounds having specified chemical functionality; steroids containing cyclohexene moiety are oxidized to corresponding alpha , beta -unsaturated ketone |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982313 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 01/03/2006 | US6982298 for tissue engineering or artificial tissue such as cartilage; hydrogels; tyramine-substituted hyaluronan molecules that are linked by dityramine bonds for example |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982285 Control of parasites attached to skin of fish |
| 01/03/2006 | US6982284 Compositions and methods for modification of skin lipid content |
| 01/03/2006 | US6982283 Method for treating drug-induced constipation |
| 01/03/2006 | US6982282 Emulsion vehicle for poorly soluble drugs |
| 01/03/2006 | US6982281 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 01/03/2006 | US6982280 cytostaticum for example; use as medicaments and plant protection agents; synthetic methods which include a Suzuki coupling or a silent coupling (stille Kupplung) |
| 01/03/2006 | US6982279 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982276 Polymorphs of an epothilone analog |
| 01/03/2006 | US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative |
| 01/03/2006 | US6982274 excellent inhibitory action on protein phosphatase (protein kinase), especially on JNK protein kinase; therapeutic or prophylactic agents for immunologic disease, inflammatory disease and/or neurodegenerative disease |
| 01/03/2006 | US6982273 Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982269 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 01/03/2006 | US6982268 Useful in the treatment of a variety of central nervous system disorders in humans including anxiety, depression, sleep disorders, attention deficit disorder, or Alzheimer's dementia |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982262 Combination of cyamemazine and an atypical neuroleptic |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |